Philippe Schaison - 13 Nov 2025 Form 4 Insider Report for Beauty Health Co (SKIN)

Reporting relationship: Director
Issuer ticker: SKIN
Reported as of: 13 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Nov 2025, 16:14:30 UTC
Prior SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Paul Bokota, Attorney-in-Fact for Philippe Schaison

Key filing fact

Philippe Schaison filed Form 4 for Beauty Health Co (SKIN) on 17 Nov 2025.

Key facts

This page summarizes Philippe Schaison's Form 4 filing for Beauty Health Co (SKIN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Nov 2025, 16:14.

Change

Previous filing in this sequence was filed on 03 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001637140 Primary reporting owner

SCHAISON PHILIPPE

Relationship: Director
Address: C/O THE BEAUTY HEALTH COMPANY, 2165 SPRING STREET, LONG BEACH
Signature: /s/ Paul Bokota, Attorney-in-Fact for Philippe Schaison
Signature date: 17 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SKIN transaction

Class A Common Stock

Award

Transaction value
Shares: +57,692
Change %
Price
Shares after: 57,692
Date: 13 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.